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Abstract
Background: Patients with type 2 diabetes are likely to have comorbid conditions which
represent a high burden for patients and a challenge for primary care physicians. The aim of this
cross-sectional survey was to assess the impact of additional comorbidities on quality of life within
a large sample of patients with type 2 diabetes in primary care.
Methods: A cross-sectional survey within a large sample (3.546) of patients with type 2 diabetes
in primary care was conducted. Quality of life (QoL) was assessed by means of the Medical
Outcome Study Short Form (SF-36), self reported presence of comorbid conditions was assessed
and groups with single comorbidities were selected. QoL subscales of these groups were compared
to diabetes patients with no comorbidities. Group comparisons were made by ANCOVA adjusting
for sociodemographic covariates and the presence of depressive disorder.
Results: Of 3546 questionnaires, 1532 were returned, thereof 1399 could be analysed. The mean
number of comorbid conditions was 2.1. 235 patients declared to have only hypertension as
comorbid condition, 97 patients declared to have osteoarthritis only. Patients suffering from
diabetes and hypertension reached similar scores like diabetic patients with no comorbidities.
Patients with diabetes and osteoarthritis reached remarkable lower scores in all subscales.
Compared to patients with diabetes alone these differences were statistically significant in the
subscales representing pain and physical impairment.
Conclusion: The impact of osteoarthritis as an often disabling and painful condition on QoL in
patients with type 2 diabetes is higher than the impact of hypertension as common but often
asymptomatic comorbidity. Individual care of patients with chronic conditions should aim at both
improving QoL and controlling risk factors for severe complications.
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Diabetes represents one of the major challenges for health
care systems all over the world while consuming a lot of
health care resources. Furthermore, some estimates pre-
dict a global increase in the number of patients suffering
from diabetes from 135 to 300 million patients until the
year 2025 [1]. Most diabetes patients suffer from type 2
diabetes.
Quality of life (QoL) in patients with diabetes is reduced
and patients are impaired in nearly all domains of daily
life [2,3]. In addition patients with diabetes are more
likely to suffer from comorbid conditions such as hyper-
tension, myocardial infarction or stroke as persons with-
out diabetes [4]. Little is known about the additional
impact of comorbid conditions on QoL in diabetics, espe-
cially in unselected patients as in primary care [5,6]. With
increasing age QoL depends more and more on the indi-
vidual health status and resulting impairments [7-9]. In
general practice it is "the rule rather than the exception" to
see patients with more than a single chronic condition
[10]. The high prevalence of multimorbidity constitutes a
high burden for the patients and a challenge for primary
care physicians simultaneously. As a consequence it is
often difficult to attribute impairments in health related
quality of life to one particular disease or chronic condi-
tion [11,12].
The aim of this cross-sectional survey was to assess quality
of life by means of the Medical Outcome Study Short
Form (SF-36) with regard to differences in the additional
impact of common comorbidities within a large sample
of patients with type 2 diabetes in primary care. In order
to assess the possible impact of particular conditions
patient groups with single comorbidities were selected.
Methods
This cross-sectional survey among patients with type 2
diabetes has been conducted as part of the ELSID study
(Evaluation of a Large Scale Implementation of Disease
Management Programmes for patients with type 2 diabe-
tes) [13]. Study protocols of the ELSID-study and the pre-
sented survey were both approved by the ethics
committee of the University of Heidelberg.
Participants
Based on the total sample observed in the ELSID-study (n
= 20.625, 59,2% female) a random sample of 3546
patients (59,3% female) was drawn. All participants were
patients with type 2 diabetes and insured by one large stat-
utory regional health care fund called Allgemeine Ortsk-
rankenkasse (AOK) which covers about 40% of the
German population. The criteria for including patients in
the ELSID study are described elsewhere [13]. For the pur-
pose of this survey patients were addressed directly by
their health insurance in November 2006 and received the
questionnaire and a postage-paid envelope addressed to
the study center. In order to ensure a high level of data pri-
vacy patients were asked to return the completed ques-
tionnaires which were only labelled with a unique
pseudonym for each patient directly to the University of
Heidelberg. Patients were informed that returning the
questionnaire would be assumed as consent for scientific
analysis of the answers. They were informed that neither
their GP nor the health insurance could get knowledge
about individual answers. Two weeks later, all patients
received a reminder (without questionnaire) regardless if
they had sent their questionnaire back or not. All patients
could participate in the draw of a prize of 6 times EURO
250 (approximately USD 375) by sending in a separate
postage-paid return envelope to the study centre. This pro-
cedure was completely separated from the questionnaires
in order to assure confidentiality.
Based on sociodemographics out of routine claims data of
the statutory health insurance we performed a non-
responder analysis including age and gender of all
addressed patients. Identification for this comparison was
based on the unique pseudonym.
Data collection
The questionnaire included the German versions of the
Medical Outcome Study Short Form (SF-36) and the 9-
item Patient Health Questionnaire (PHQ-9) as well as
sociodemographic questions.
The SF-36 is a generic questionnaire for measuring health-
related QoL, which is often used in international studies.
[14,15] The SF-36 provides scores in eight domains (Phys-
ical functioning (PF), Role-physical (RP), Bodily Pain
(BP), General Health (GH), Vitality (VT), Social Function-
ing (SF), Role-Emotional (RE) and Mental Health (ME)).
In addition two summary measures labelled as the Physi-
cal component summary scale (PCS) and the Mental com-
ponent summary scale (MCS) [14,15] can be calculated.
The scores range from 0 to 100, higher values represent a
better QoL. We compared the results of the present sam-
ple of patients with type 2 diabetes with data of the gen-
eral population extracted out of the German National
Health Interview and Examination Survey [16]. Therefore,
according to normative data we divided the study sample
into 4 age groups (50–59, 60–69, 70–79, 80 and more).
The 9-item Patient Health Questionnaire (PHQ-9) is a
self-administered, well validated and widely used diag-
nostic instrument to assess depressive symptoms and
severity of depressive disorders [17,18]. It provides a sum-
mary score ranging from 0 to 27, with higher values indi-
cating higher severity. A cut-off value of 10 has beenPage 2 of 7
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0.88 [18].
Sociodemographic data included age, gender, educational
level, occupational status, partnership/marital status and
the monthly household-income. Furthermore, self-
administered information about the presence of the fol-
lowing conditions was collected: hypertension, coronary
heart disease, myocardial infarction, congestive heart fail-
ure, stroke, asthma, chronic bronchitis, gastric ulcer, can-
cer and osteoarthritis. Out of this information we
calculated the mean total number of conditions and
selected patient groups with the most frequently declared
single comorbidities.
In order to calculate the body mass index (BMI) we
recorded height and weight of the patients. We assessed
the socioeconomic status (SES) with a non-weighted
social class index based on the three dimensions educa-
tion, occupation and household-income. Based on a score
with possible ranges from 3 to 21 points three social
classes (lower, middle, upper) were defined [19].
Statistical analysis
All statistical analyses were performed using the SPSS soft-
ware program (version 15.0). Unadjusted group compar-
isons of continuous variables (reported in terms of means
and standard deviations) were made using the student's t
test or the Mann-Whitney-Test as appropriate. Normality
of distribution was tested by means of the Kolmogorov-
Smirnov test. The chi-square test was used for categorial
variables. For the analysis of an additional impact of spe-
cific comorbid conditions on QoL we selected patient
groups with one single comorbid condition. Differences
between these groups were analysed by ANCOVA adjust-
ing for possible confounders that may have an influence.
These covariates were age (50–59 years, 60–69 years, 70–
79 years, > 80 years), gender, SES (lower, middle, upper
social class), BMI (<25, 25–30, >30) and depressive disor-
der (<10, ≥ 10) . To avoid effects of multiple testing post
hoc corrections according to Bonferroni were performed.
The level of significance was defined as p < 0.05.
Results
1532 of 3546 questionnaires were returned (response rate
43.2%), 1399 were eligible for further analysis.
Non-Responder-analysis
Responder were younger than non-responder (responder:
70.3 years [95% CI 69.9; 70.7], non-responder 71.8 years
[71.4; 72.2]), p < 0.001. Of the responder 686 were male
(46.6%) and 787 were female (53.4%); among the non-
responder 736 were male (35.5%) and 1337 (64.6%)
were female.
Sociodemographic data
Table 1 shows sociodemographic characteristics of the
study sample. Of 1399 included patients 649 were male
(46.4%) and 750 were female (53.6%). The mean
number of comorbid conditions was 2.1 (range 0–8). 904
patients (64.6%) were married or lived in partnership
respectively. 1068 patients (76.3%) were grouped as "low
socioeconomic status", according to the mentioned scor-
ing. The number of smokers was 117 (8.4%).
Health related quality of life
Table 2 shows means for the eight domains of the SF-36
scales and the two component scales for the total sample
of patients with type 2 diabetes in comparison to norma-
tive data. All data for each of the eight SF-36 subscales
were not normally distributed. Compared to the general
population QoL was worse in all domains reaching statis-
tical significance in all subscales.
Number of Comorbidities
Hypertension (71.6%) and osteoarthritis (57.0%) were
the most common comorbid conditions. With declining
frequency other conditions were stated as following: cor-
onary vessel disease (20.7%), congestive heart failure
(17.3%), chronic bronchitis (10.3%), cancer (8.1%),
myocardial infarction (7.5%) stroke (6.2%), asthma
(4.3%), gastric ulcer (3.5%).
Table 1: Sociodemographic characteristics of the study sample
Total N = 1399
Gender female
Number (%) 750 (53.6)
Age
Mean [95% CI] 70.3 (8.5)
Married/living in partnership
No (%) 904 (64.6)
Socioeconomic Status
No. (%)
Low 1068 (76.3)
Middle 221 (15.8)
High 20 (1.4)
≤9 years of education
Number (%) 998 (71.3)
Annual income
Number (%)
< 15000 689 (49.2)
15000–36000 632 (45.2)
>36000 78 (5.6)
Smoker
Number (%) 117 (8.4)
BMI
Mean (SD) 30.3 (6.1)
No. of comorbid conditions
Mean (SD) 2.1 (1.4)
SD = Standard deviationPage 3 of 7
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scales reached lower values as we displayed in figure 1.
Additional impact of comorbid conditions
Table 3 presents the scores for the SF-36 subscales and the
two component scales for diabetics without any comorbid
condition as well as for patients with hypertension or
osteoarthritis. 147 patients indicated to have only diabe-
tes (mean age 70.3 years [95% CI: 68.80; 71.81], 53.7%
female). 235 patients declared to have hypertension as
only comorbid condition (mean age 68.02 years [95% CI:
66.94;69.09], 56.2% female). As can be seen patients with
hypertension achieve higher scores than patients with dia-
betes only. Adjusted for age, BMI, gender, SES and depres-
sive disorder these differences did not reach statistical
significance neither in the 8 subscales nor in the two com-
ponent scales. 97 patients declare to have osteoarthritis as
only comorbid condition (mean age 69.93 years [95% CI:
68.10; 71.76], 48.5% female). Patients with osteoarthritis
had remarkable lower scores in all SF36 domains. Com-
pared to the diabetes patients without comorbidities, the
differences were statistically significant in the subscales
Physical functioning (p < 0.001), Role physical (p < 0.05),
Bodily pain (p < 0.001), General health (p < 0.05), Social
functioning (p < 0.05) and furthermore the Physical com-
ponent scale (p < 0.001). Finally, table 3 displays the
Table 2: SF36 scales compared to normative data
PF RP BP GH VT SF RE MH PCS MCS
Total sample Total sample
N = 1399
51.04
(30.38)
44.50
(44.98)
50.10
(28.91)
47.41
(18.87)
45.23
(21.71)
70.30
(27.26)
63.69
(45.59)
63.84
(21.64)
36.49
(11.65)
47.67
(11.53)
Norm 85.71
(22.10)
83.70
(31.73)
79.08
(27.38)
68.05
(20.15)
63.27
(18.47)
88.76
(18.40)
90.35
(25.62)
73.88
(16.38)
50.21
(10.24)
51.54
(8.14)
p-Wert* <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
* p-values in the table concern the comparison to normative data
PF = Physical functioning, RP = Role physical, BP = Bodily pain, GH = General health, VT = Vitality, SF = Social functioning, RE = Role emotional, ME 
= Mental health, PCS = Physical component scale, MCS = Mental component scale
SF36 subscales depending on the number of comorbiditiesFigure 1
SF36 subscales depending on the number of comorbidities. PF = Physical functioning, RP = Role physical, BP = Bodily 
pain, GH = General health, VT = Vitality, SF = Social functioning, RE = Role emotional, ME = Mental health.
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tension (mean age 69.65 years, [95% CI 68.72; 70.57],
59.0% female), which were similar or higher than those of
patients with osteoarthritis alone. Compared to patients
without comorbidities all scores were lower reaching sta-
tistical significance in Physical functioning (p < 0.001),
Role physical (p < 0.05), Bodily pain (p < 0.001), General
health (p < 0.01), Vitality (p < 0.05) and the Physical com-
ponent scale (p < 0.001).
Discussion
In this cross-sectional survey performed in a primary care
setting, QoL in patients with type 2 diabetes is signifi-
cantly lower compared to the general population. Addi-
tionally, this study revealed declining scores for all SF-36
subscales with an increasing number of comorbid condi-
tions. The most common comorbid conditions reported
were hypertension and osteoarthritis with osteoarthritis
having remarkable more impact on quality of life than
hypertension.
Over the last two decades health related quality of life,
individual health status or well-being have gained more
importance as patient-relevant outcome parameters
within medical and health services research [7]. Especially
for patients suffering from one or several chronic condi-
tions care should focus on the best possible management
of the disease and additional impairments on daily life
instead of recovery and health. [2,20]. For older patients
improvements within QoL may often have a more impor-
tant role than a possible extension of life time ("add life
to years, not years to life") [21,22].
Comparable to results of other studies [3,23-25] patients
with type 2 diabetes in our sample were limited in all
scores of the SF-36 compared to people without diabetes.
According to the literature the number of comorbid con-
ditions was associated with a lower quality of life in all
domains of the SF-36 [26,27]. Interestingly in our study
patients with hypertension and diabetes achieved higher
scores than patients with only diabetes. However, these
differences did not reach statistical significance after
adjusting for relevant variables. These findings are in
accordance with previous studies, describing similar qual-
ity of life scales of patients with hypertension and those
without any chronic condition [28,29]. One reason for
this finding may be that hypertension is often asympto-
matic and physically less impairing than other diseases.
However, other studies showed hypertensive patients to
have lower scales in QoL than normotensive patients
because of adverse effects of drugs used in the treatment
of the high blood pressure [30] or because of a so called
labelling effect [31]. Wee et al. assumed that there are
chronic conditions with non-additional effects on health
related QoL, so that having both conditions is not more
disabling than having one of them [6]. Sprangers et al.
describe a mechanism of accommodation to a chronic ill-
ness with changes in internal standards and values – the
so called "response shift" [12].
It is important to keep in mind that hypertension perhaps
does not intensify the burden for the patients since high
blood pressure levels represent a major risk factor for car-
diovascular mortality and morbidity especially for
patients with type 2 diabetes [32]. This has to be taken
into account as an additional and important risk factor,
both from patients and from physicians [28].
Regarding osteoarthritis as comorbidity we found remark-
able lower scales in all domains of the SF-36 in particular
within the subscales related to physical well-being. The
revealed high burden of patients with osteoarthritis is in
accordance with other studies and congruent with the
clinical experience of primary care physicians [33-36].
Major problems for patients with osteoarthritis are pain
and disability. These symptoms are associated with an
increased health service utilization [35,37,38] and have to
Table 3: SF-36 subscales and component scales in patients with diabetes, hypertension and osteoarthritis (all data were mean and SD)
PF RP BP GH VT SF RE MH PCS MCS
Diabetes without comorbidity
(n = 147)
65.77
(30.44)
62.42
(44.20)
66.94
(30.26)
55.82
(20.17)
52.09
(23.78)
77.69
(23.82)
66.83
(43.91)
69.21
(21.25)
43.45
(11.38)
48.75
(10.93)
Diabetes and Hypertension
(n = 235)
70.02
(26.14)
72.21
(40.26)
72.89
(27.01)
57.79
(17.15)
58.33
(21.05)
81.47
(22.52)
82.52
(35.08)
72.79
(17.88)
45.51
(9.52)
51.49
(9.09)
Diabetes and osteoarthritis
(n = 97)
49.99 ***
(27.90)
41.46*
(44.56)
44.21***
(21.54)
50.46*
(17.06)
47.98
(18.84)
71.60*
(26.99)
62.45
(44.46)
65.68
(18.33)
35.30***
(10.50)
48.31
(10.11)
Diabetes, hypertension and 
osteoarthritis
(n = 271)
53.08 ***
(28.04)
45.50*
(45.12)
44.60***
(23.99)
49.13**
(18.02)
46.93*
(19.42)
74.25
(26.78)
68.06
(44.92)
66.35
(20.83)
35.93***
(11.07)
49.31
(11.80)
PF = Physical functioning, RP = Role physical, BP = Bodily pain, GH = General health, VT = Vitality, SF = Social functioning, RE = Role emotional, ME 
= Mental health, PCS = Physical component scale, MCS = Mental component scale
All group comparisons are versus Diabetes without comorbidity (adjusted for age, bmi, gender, ses and depressive disorder)
* p < 0.05; ** p < 0.01; *** p < 0.001Page 5 of 7
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concomitant osteoarthritis.
The list of self reported comorbidities used in this survey
did not contain any mental conditions like e.g. depres-
sion, so we were not able to assess the possible impact of
these potential comorbidities as we did with somatic
comorbidities. However, the used set of questionnaires
contained the PHQ-9 as a screening instrument for
depressive disorder. This enabled us to control our data
for this important issue [12,26]. To evaluate the impact of
mental comorbidity on QoL in primary care further
research is still needed.
The present study has some limitations. First of all the
results were cross-sectional, any conclusions on causality
are impossible. All data were self reported, some chronic
conditions could be under- or overreported. All questions
were filled out self-dependent, considering the mean age
of the participants misconceptions could not be excluded.
Furthermore calculating the BMI out of self reported
height and weight is associated with a limited validity
especially in older adults [39,40]. Smoking rates in our
sample were self reported too. But there is some evidence
that the validity of self-reported smoking within survey
studies is reasonable [41]. Furthermore the BMI and the
percentage of smokers in our study sample were compara-
ble to findings in the primary care population in the US
and Germany [42-44].
The most important limitation might be that we had no
knowledge about the severity of the addressed comorbid-
ities. A fact which might limit generalizability of our find-
ings is that all participants of our survey were from the
same regional health fund. This insurance fund covers a
sample with a higher proportion of elder insurants and a
higher prevalence of multimorbidity than other insurers
in Germany.
The response rate of our survey was moderate, but a non-
responder analysis could be performed, showing that
non-responder were slightly older and more likely to be
female. The response rates might have been higher if the
questionnaires would have been sent out by the university
department directly [45] instead of the health insurance
fund. However, due to a strict protection of data privacy
we weren't able to contact the patients directly.
Strengths of our study were the large and heterogeneous
study sample collected in a primary care setting. Since
patients' selection was primarily conducted by using rou-
tine claims data and secondarily by drawing a random
sample selection bias is unlikely.
Conclusion
This large survey provided a more differentiated view on
QoL of patients with type 2 diabetes in primary care
regarding the common comorbid conditions hyperten-
sion and osteoarthritis and therefore contributes to a bet-
ter understanding of diabetic patients. The study
emphasized that osteoarthritis as a common, disabling
and painful comorbid condition has a stronger impact on
QoL than hypertension. Individualized care of patients
with chronic conditions should consider both improving
QoL and controlling risk for severe complications. For pri-
mary care physicians this constitutes a challenge with dif-
ferent faces and requires awareness of the patients'
differentiated perception. In order to affect QoL in pri-
mary care osteoarthritis should get more attention as asso-
ciated pain and disability are more important from a
patients' point of view as hypertension. Simultaneously
efforts for advising and patient education should focus on
hypertension as asymptomatic but important risk factor.
Chronic conditions and multimorbidity are an important
and increasing challenge for GPs. So far most studies
focussed on the impact of one condition on QoL. As our
results suggest it is important to assess several conditions
and their impact on individual QoL. This should be con-
sidered within further research.
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